Analysis of Risk Factors for Sorafenib Treatment: A Retrospective Study

Analysis of Risk Factors for Sorafenib Treatment: A Retrospective Study

碩士 === 中國醫藥大學 === 公共衛生學系碩士班 === 106

Bibliographic Details
Main Authors:	Chien-Hung Liao, 廖健宏
Other Authors:	Pei-Chun Chen
Format:	Others
Language:	en_US
Published:	2018
Online Access:	http://ndltd.ncl.edu.tw/handle/zs9ehb

Similar Items

The Drug Resistance Mechanism of Liver Cancer Stem Cells in Sorafenib Treatment
by: LIAO, CHEN-CHUN, et al.
Published: (2018)

A real-life experience of sorafenib treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis at Cathay General Hospital, 2007–2015
by: Huang CC, et al.
Published: (2019-01-01)

Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
by: Anne Helene Køstner, et al.
Published: (2013-01-01)

Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
by: Wang Y, et al.
Published: (2018-06-01)

Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma.
by: Yushi Zhang, et al.
Published: (2015-01-01)

Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan
by: Chen-Yuan Lin, et al.
Published: (2021-01-01)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Junji Furuse
Published: (2008-11-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Necrotizing fasciitis associated with sorafenib treatment
by: Ho Won Kang, et al.
Published: (2019-01-01)

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
by: Sangheun Lee, et al.
Published: (2013-01-01)

Radiosensitization effect of Sorafenib in hepatocellular carcinoma treatment
by: John Chun-Hao Chen, et al.
Published: (2018)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
by: Soo Young Kim, et al.
Published: (2018-10-01)

Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
by: Wu J, et al.
Published: (2017-05-01)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
by: Khaldoun Almhanna, et al.
Published: (2009-11-01)

Selective use of sorafenib in the treatment of thyroid cancer
by: Pitoia F, et al.
Published: (2016-03-01)

Sorafenib-induced acute pancreatitis
by: Han-En Wang, et al.
Published: (2014-01-01)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01)

Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy
by: Wang D, et al.
Published: (2019-07-01)

Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study
by: Sung Han Kim, et al.
Published: (2017-01-01)

THE SAFETY AND TOLERABILITY OF SORAFENIB IN THE TREATMENT OF EXTENSIVE RENAL CANCER
by: V. A. Biryukov, et al.
Published: (2014-07-01)

Experience with sorafenib in the treatment of advanced renal cell carcinoma
by: Giuseppe Procopio, et al.
Published: (2012-12-01)

THE SAFETY AND TOLERABILITY OF SORAFENIB IN THE TREATMENT OF EXTENSIVE RENAL CANCER
by: V. A. Biryukov, et al.
Published: (2014-07-01)

Sorafenib in Mice – A Pharmacokinetic Study
by: R. Abbiati, et al.
Published: (2015-05-01)

A New Algorithm for Scalar Point Multiplication in Elliptic Curve Cryptography
by: Chien-Hung Liao, et al.
Published: (2007)

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
by: Carolina Méndez-Blanco, et al.
Published: (2018-10-01)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
by: Oronzo Brunetti, et al.
Published: (2019-10-01)

A Retrospective Study of Factors Affecting Long-term Survival in Dogs with Multicentric Lymphomas after Treatment
by: Chih-Chieh Liao, et al.
Published: (2018)

Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study
by: Hanzel Jurij, et al.
Published: (2020-05-01)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
by: Liyun Zheng, et al.
Published: (2021-01-01)

Effect of sorafenib in a murine high risk penetrating keratoplasty model
by: Yang Kyung Cho, et al.
Published: (2017-06-01)

Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
by: Anne Clavreul, et al.
Published: (2018-01-01)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
by: Hitomi Takada, et al.
Published: (2018-01-01)

Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
by: Tomuleasa C, et al.
Published: (2013-10-01)

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
by: Imane El Dika, et al.
Published: (2017-12-01)

An Exploratory Study on the Risk Factors of Commercial Fire Insurance Underwriting
by: Liao,Jian-Yan, et al.
Published: (2017)

A Case Study on Information Security Risk Management Models
by: CHIEN-HSING LIAO, et al.
Published: (2008)

Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
by: Wen Cai, et al.
Published: (2019-10-01)

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki Young Huh, et al.
Published: (2021-04-01)

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
by: Anna-Maria Pehserl, et al.
Published: (2016-12-01)

Cannot write session to /tmp/vufind_sessions/sess_o3hejp8jbdg1jml8gvi76692id